15
Total investments
6
Early stage
1
Mid stage
2
Late stage
6y
Years active
Portfolio
11 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Oct 2024
Cellular carriers around the globe are rolling out high-bandwidth 5G networks to satisfy the insatiable, global demand for data and connectivity. While these new networks hold amazing promise to enable a much more connected world, the power consumption required by 5G networks is significantly higher than that of existing 4G/LTE networks, causing operational and sustainability headaches for wireless carriers and private network operators.
THW develops the world’s most energy-efficient Smart Network Towers, including remote radio heads (RRH), which is the hardware box that sits at the top of the cell tower. Carrier networks deploying THW remote radio heads expect significant reductions in total cost of ownership. The savings directly impact wireless carriers’ bottom line and enable critical corporate ESG imperatives around climate change and GHG emissions reductions.
Investor
Apr 2024
TelyRx is a technology-enabled healthcare company that facilitates telehealth encounters for non-controlled, everyday medications. We believe that access to essential medicines should be simple, convenient, and available to all. Our mission is to increase access to medications people need by removing unnecessary barriers, streamlining the process, and making the drugs as affordable as we can.
Independent providers use the TelyRx platform to enable patients to efficiently obtain medications that are right for them through telehealth, and as a pharmacy, we ship the medicine right to the patients door with next-day delivery. We work with doctors, veterinarians, practice groups, and other licensed prescribers who use telehealth to help better serve their patients. TelyRx allows providers and practice groups to provide a concierge pharmacy experience improving patient engagement and satisfaction.
Investor and Board Member
Jan 2024
Splice Histology provides individual histology services which consist of tissue processing, embedding, microtomy and H&E staining.
Investor
Jan 2024
Kytopen is focused on the development and commercialization of groundbreaking genome engineering platforms for expediting the discovery, development, and manufacture of gene-modified cell therapies. Developed at MIT, the Flowfect® platform, harmonizing microfluidics and automation, revolutionizes the delivery of genome engineering materials to cells of therapeutic interest in an expeditious, scalable, and economically advantageous manner compared to current alternatives. In May 2023, Kytopen unveiled the Flowfect Discover™, an automated high-throughput genome engineering platform, and disclosed strategic partnerships with industry-leading Contract Development and Manufacturing Organizations (CDMOs) and translational academic medical centers. By combining Flowfect Discover™ with the Flowfect Tx™ large-scale delivery device in process development workflows, developers can now surmount manufacturing challenges during the discovery stage, fostering swifter and more cost-effective innovation.
Investor
Oct 2021
Domus Diagnostics is working to create infectious disease diagnostic tests that are affordable, user-friendly, accurate, and rapid enough to address the needs raised by current and future public health crises.
Investor
May 2021
The Pharmacy Benefits Savings Experts
Scripta is a unique company dedicated to stopping out of control pharmacy benefit spending before it starts for self-insured employers. Our exclusive software analyzes all pharmacy transactions every month, compares them to your PBM contract, and to our exclusive Med Mapping Software. The result? A level of transparency and cost-control never before available to payers. Our clients see savings of up to 35% on their pharmacy benefit spend. Scripta…your data, our platform, big savings™!
Board Member
Mar 2021
RTR is dedicated to serving individuals with intellectual disabilities, emotional/behavioral challenges and complex medical needs. Now ranked among the largest and most effective human service providers, RTR has gained national recognition for the quality of its residential, employment and day habilitation programs.
Professional integrity and respect for those we serve are the guiding principles behind RTRs extraordinary success. Our mission is simple: To provide the means, the opportunity and the support necessary to allow people with disabilities to take their place as productive members of the community.
Investor
Dec 2020
Boston Cell Standards developed the world’s first calibrators and controls for immunohistochemistry testing, introducing standardized units of measure (molecules per cell) linked with an international standard (NIST SRM 1934).
This breakthrough opens new opportunities for improved disease understanding, diagnosis, and treatment. In the clinical environment, our IHControls are being used in place of traditional control tissue. Our IHCalibrators are being used for new assay work-up, calibration of instrumentation, and as part of a QA/QC process to track day-to-day variabilities. In the pharma/life science arenas, BCS products are being used by primary investigators in early-stage drug development (in lieu of costly commercial controls) and by CROs at the onset of clinical trials (to ensure instrument and assay accuracy), to name a few uses.
Interested in learning more? Contact us through our online form: http://bostoncellstandards.com/contact-us/
Board Member
Jul 2020
Anodyne is a venture-backed, clinical-stage biotech company focused on simplifying chronic care for all stakeholders. We specialize in the transdermal delivery of multi-milligram doses and complex formulations, enabling easier access to both existing therapies and emerging large molecule treatments.
The HeroPatch, our proprietary technology represents a breakthrough in drug delivery. By transdermally delivering large molecules, it enables tunable pharmacokinetic profiles, new formulations using APIs in dry form, room temperature stability, and combination therapies of next-generation therapeutics.
Our product pipeline is dedicated to addressing the unmet needs of chronic diseases, with an initial focus on obesity. We are committed to delivering innovative solutions that significantly impact patients’ lives.
Anodyne is actively expanding its pipeline through both internal clinical development and strategic external partnerships, maximizing the commercial potential and clinical impact of our advanced drug delivery platform.
Investor
Jul 2020
Boston, Massachusetts-based QSM Diagnostics Inc. is fundamentally changing how bacterial infections are diagnosed and treated. The companys patented technology allows veterinarians to diagnose and monitor bacterial infections in companion animals rapidly and accurately.
Board Member
Jan 2020
Ompractice is an innovative preventative health platform delivering evidence-based movement and mindfulness (think yoga, meditation, tai-chi and more) for large corporates and health systems. We address physical and mental population health at scale using two-way video, providing disproportionate access to these modalities to those who need it most, when and where it works for them. With over 100+ live two-way group classes per week, we create real opportunities for behavior change that address the specific population health objectives of our many corporate and government partners.
Experience · 17 entries
All (17)
Investments (15)
Board (7)
2024
Investor
Oct 2024
Cellular carriers around the globe are rolling out high-bandwidth 5G networks to satisfy the insatiable, global demand for data and connectivity. While these new networks hold amazing promise to enable a much more connected world, the power consumption required by 5G networks is significantly higher than that of existing 4G/LTE networks, causing operational and sustainability headaches for wireless carriers and private network operators.
THW develops the world’s most energy-efficient Smart Network Towers, including remote radio heads (RRH), which is the hardware box that sits at the top of the cell tower. Carrier networks deploying THW remote radio heads expect significant reductions in total cost of ownership. The savings directly impact wireless carriers’ bottom line and enable critical corporate ESG imperatives around climate change and GHG emissions reductions.
Investor
Apr 2024
TelyRx is a technology-enabled healthcare company that facilitates telehealth encounters for non-controlled, everyday medications. We believe that access to essential medicines should be simple, convenient, and available to all. Our mission is to increase access to medications people need by removing unnecessary barriers, streamlining the process, and making the drugs as affordable as we can.
Independent providers use the TelyRx platform to enable patients to efficiently obtain medications that are right for them through telehealth, and as a pharmacy, we ship the medicine right to the patients door with next-day delivery. We work with doctors, veterinarians, practice groups, and other licensed prescribers who use telehealth to help better serve their patients. TelyRx allows providers and practice groups to provide a concierge pharmacy experience improving patient engagement and satisfaction.
Investor and Board Member
Jan 2024
Splice Histology provides individual histology services which consist of tissue processing, embedding, microtomy and H&E staining.
Investor
Jan 2024
Kytopen is focused on the development and commercialization of groundbreaking genome engineering platforms for expediting the discovery, development, and manufacture of gene-modified cell therapies. Developed at MIT, the Flowfect® platform, harmonizing microfluidics and automation, revolutionizes the delivery of genome engineering materials to cells of therapeutic interest in an expeditious, scalable, and economically advantageous manner compared to current alternatives. In May 2023, Kytopen unveiled the Flowfect Discover™, an automated high-throughput genome engineering platform, and disclosed strategic partnerships with industry-leading Contract Development and Manufacturing Organizations (CDMOs) and translational academic medical centers. By combining Flowfect Discover™ with the Flowfect Tx™ large-scale delivery device in process development workflows, developers can now surmount manufacturing challenges during the discovery stage, fostering swifter and more cost-effective innovation.
2022
Board Member
Jan 2022
More than 21,000 students enrolled in Massachusetts public schools are identified as homeless. The mission of School on Wheels of MA (SOWMA) is to support the academic, social and emotional growth of students impacted by homelessness and poverty. We provide tutoring, mentoring and customized, grade-level backpacks and school supplies to students grades Pre-K through college-age to help them succeed in school and reach their potential.
Show all 17 entries ↓
Investment activity
2020–2024 · 15 investments
Recent (last 2 years)Earlier
